BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10675688)

  • 1. Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres.
    Sah H
    Int J Pharm; 2000 Feb; 195(1-2):103-13. PubMed ID: 10675688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
    Cho M; Sah H
    J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent hydrolysis rate determines critical quality attributes of PLGA microspheres prepared using non-volatile green solvent.
    Kim H; Kim S; Sah H
    J Biomater Sci Polym Ed; 2018 Jan; 29(1):35-56. PubMed ID: 29086633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
    Im HY; Sah H
    Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse micelle-based microencapsulation of oxytetracycline hydrochloride into poly-d,l-lactide-co-glycolide microspheres.
    Kim H; Lee BJ; Sah H
    Drug Deliv; 2007 Feb; 14(2):95-9. PubMed ID: 17364873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhalogenated solvent-based solvent evaporation process useful in preparation of PLGA microspheres.
    Jang J; Sah H
    J Microencapsul; 2011; 28(6):490-8. PubMed ID: 21827356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on structural integrity of PLGA during ammonolysis-based microencapsulation process.
    Heo S; Lee M; Lee S; Sah H
    Int J Pharm; 2011 Oct; 419(1-2):60-70. PubMed ID: 21839820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone.
    Sah H; Smith MS; Chern RT
    Pharm Res; 1996 Mar; 13(3):360-7. PubMed ID: 8692726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres.
    Perugini P; Genta I; Pavanetto F; Modena T; Maculotti K; Conti B
    J Microencapsul; 2002; 19(5):591-602. PubMed ID: 12433302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of acid-catalyzed hydrolysis of dispersed organic solvent in developing new microencapsulation process technology.
    Lee H; Lee S; Bhattacharjee H; Sah H
    J Microencapsul; 2012; 29(4):380-7. PubMed ID: 22299629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.
    Wang FJ; Wang CH
    J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified emulsion solvent evaporation method for fabricating core-shell microspheres.
    Xiao CD; Shen XC; Tao L
    Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
    Iwata M; McGinity JW
    J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel-loaded PLGA nanoparticles: preparation and characterization.
    Mainardes RM; Evangelista RC
    J Microencapsul; 2005 Feb; 22(1):13-24. PubMed ID: 16019887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.
    Shim H; Sah H
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32384751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
    Haddadi A; Farboud ES; Erfan M; Aboofazeli R
    J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another paradigm in solvent extraction-based microencapsulation technologies.
    Im HY; Kim J; Sah H
    Biomacromolecules; 2010 Mar; 11(3):776-86. PubMed ID: 20131759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
    Zaghloul AA; Mustafa F; Siddiqui A; Khan M
    Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.